Notice of Effectiveness

HCW Biologics Inc. Filed 2022-08-26 Acc 9999999995-22-002524

Documents 1

2025-04-16 EFFECT Notice of Effectiveness
2022-08-30 4 Chief Financial Officer bought 20,000 shares at an average $2.55 ($51,020)
2022-08-26 EFFECT Notice of Effectiveness
2022-08-26 4 Chief Financial Officer bought 90,300 shares at an average $2.54 ($229,747)
2022-08-25 CORRESP Correspondence Between Filers and SEC Staff
2022-08-24 UPLOAD SEC-generated Letter
2021-07-19 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…